IRONDisc Medicine, Inc.
$62.08+2.1% 1Y
$62.08
$55.9552 weeks$94.11
IRON as reported
- Net income
- −$246M
Net income · +69% year on year · trailing twelve months to Q2 2026
- Free cash flow
- −$198M
Free cash flow · +46% year on year · trailing twelve months to Q2 2026
- EPS
- −$6.58
EPS · +47% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$246M | +69% | Q2 2026 |
| EPS | −$6.58 | +47% | Q2 2026 |
| ROE | −33% | n/a | Q2 2026 |
| ROA | −30% | n/a | Q2 2026 |
| ROIC | 1304% | n/a | Q2 2026 |
| Free cash flow | −$198M | +46% | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Disc Medicine, Inc. (IRON) · Net incomeNet incomeDisc Medicine, Inc. (IRON)
On our screens:Most shorted stocks